Raynaud's Syndrome Completed Phase 0 Trials for Sildenafil (DB00203)

Also known as: Raynaud’s phenomenon / Raynaud's Phenomenon / Raynaud’s syndrome / Raynaud Syndrome / Raynaud / Raynaud's Disease / Raynaud phenomenon / Raynauds / Raynaud's syndrome NOS / Raynauds' phen / Raynaud Disease

IndicationStatusPhase
DBCOND0049133 (Raynaud's Syndrome)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03027674Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary RaynaudTreatment